Abstract
Objectives The goals of this review are to evaluate the quality of the evidence on epidemiology of SCA/D in athletes and military members; and to synthesize existing data to estimate annual incidence of SCA/D.
Design Systematic review and meta-analysis.
Data Sources MEDLINE, Embase, Cochrane CENTRAL, Web of Science, BIOSIS, Scopus, SPORT discus, PEDro, were searched from inception to date searched between 2/21/19 and 3/1/19, and Clinicaltrials.gov on 7/29/19. All databases were searched without limits on language.
Eligibility for selecting studies Studies which report incidence, or data from which incidence can be calculated, of SCA/D or both in athletes, or military members age 40.
Results 40 total studies were included. Overall quality of the evidence was judged to be poor. 35 of 40 included studies reported 1,902 events of SCD over 404,268,083 person years and a pooled incidence rate of 1.39events per 100,000 person years (95% CI: 0.80, 2.43) with high heterogeneity (I2=99%). 11 studies reported 219 events of SCA over 13,450,396 person years and a pooled incidence rate of 3.05 events per 100,000 person years (95% CI: 1.42, 6.58) with high heterogeneity (I2=96%).
Conclusion The worldwide incidence of sudden cardiac death and arrest in young otherwise healthy athletes and military personnel is low. Available subgroup analysis showed incidence rates were highest in males; military members, elite athletes; and soccer athletes. Findings are tempered by unexplained heterogeneity and risk of bias in included studies.
PROSPERO Registration: CRD42019125560
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PROSPERO: CRD42019125560
Funding Statement
No funding was received for this project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Systematic review. IRB exempt.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Contact author: Aaron Lear 1 Akron General Way Ctr for Fam Medicine Akron, OH 44307 USA leara{at}ccf.org office: 330.344.6047 (Angela Watkins assistant)
Data Availability
Reasonable requests for data will be considered by email request to first author.